The global 中国·银河贵宾汇(GALAXY):chitosan market size was valued at USD 3.1 Billion in 2025, and it is expected to reach USD 7.7 Billion by 2034♒, exhibiting a growth rate (CAGR) of 10.10% from 2026꧅ to 2034.
The medical industry is increasingly focusing on unique hemostatic remedies, particularly chitosan-based products. These advanced materials are getting regulatory approval for their efficacy in reducing severe bleeding, especially in trauma care and military applications. For example, in July 2023, Axio Biosolutions Pvt Ltd acquired 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Axiostat Gauze line of enhanced hemostatic gauze, which prevents severe traumatic bleeding. Axiostat in Z-fold Hemostatic gauze is based on a biomaterial technology that is 100% chitosan-based and has already achieved CE certification. It is utilized by several military forces across the world to minimize trauma bleeding. Moreover, collaborative innovation is becoming increasingly important in agriculture, notably in the development of improved crop protection systems. Companies are increasingly collaborating to offer unique, effective components that solve specific difficulties, such as weed control in rice farming, resulting in increased crop yields. For instance, in May 2023, FMC Corporation established a partnership with Syngenta Crop Protection to offer a ground-breaking weed control solution for rice. Tetflupyrolimet, the novel active component, was discovered and developed by FMC for use in rice with assistance from Syngenta. Furthermore, chitosan manufacturers targeting the health and wellness market are capitalizing on rising customer interest in natural weight control solutions and dietary supplements. As a result of this, they are developing chitosan products to help reduce fat absorption and enhance digestive health. Additionally, the increased demand for functional foods presents huge economic prospects for manufacturers. Also, due to their better effectiveness, customers are increasingly preferring high-quality and bioavailable chitosan formulations to traditional and lower-quality alternatives. For example, premium chitosan supplements are in high demand in North America, owing to brands such as Nature's Way and Now Foods, which sell chitosan as a natural fat blocker and nutritional assistance. These firms focus on providing scientifically supported and high-potency chitosan products to the region's health-conscious customer base, which contributes to the rising popularity of natural weight control options.The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. According to the report, Asia-Pacific accounted for the largest chitosan market share on account of the region's substantial population, rapid urbanization, and the growing industrial sectors.
Some of the leading chitosan market companies include Primex EHF, Heppe Medical Chitosan GmbH, Meron Group, KitoZyme SA, Golden-Shell Pharmaceutical Co. Ltd., FMC Corporation, Agra Tech, Inc., Axio Biosolutions Pvt Ltd., and Marshall Marine Products, among many others. For example, in March 2023, Meron Group released new dessert premixes for HoReCA. The company's launch concentrates on ready-to-use premixes and specialized blends.
| Report Features | Details |
|---|---|
| Market Size in 2025 | USD 3.1 Billion |
| Market Forecast in 2034 | USD 7.7 Billion |
| Market Growth Rate 2026-2034 | 10.10% |
| Units | Billion USD |
| Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
| Grades Covered | Industrial Grade, Food Grade, Pharmaceutical Grade |
| Sources Covered | Shrimp, Crab, Squid, Krill, Others |
| Applications Covered | Water Treatment, Food & Beverages, Cosmetics, Medical & Pharmaceuticals, Agrochemicals, Others |
| Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Companies Covered | Primex EHF, Heppe Medical Chitosan GmbH, Meron Group, KitoZyme SA, Golden-Shell Pharmaceutical Co. Ltd., FMC Corporation, Agra Tech, Inc., Axio Biosolutions Pvt Ltd., Marshall Marine Products. etc. |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |